Loading clinical trials...
Loading clinical trials...
Patient-controlled Propofol Sedation for Endoscopic Retrograde Cholangiopancreatography
Propofol sedation with opioids is used for endoscopic retrograde cholangiopancreatography (ERCP). Combination of sedatives and opioids is associated with increased morbidity/mortality. Delivery of only propofol using a patient-controlled delivery system (patient-controlled sedation, PCS) could be an alternative for this purpose. Comparative studies with PCS for ERCP are few. Therefore, the main objective of this randomized controlled trial was to compare propofol PCS to sedation managed by nurse anaesthetists during ERCP.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Linköping University Hospital
Linköping, Sweden
Start Date
October 1, 2010
Primary Completion Date
May 1, 2012
Completion Date
May 1, 2012
Last Updated
November 9, 2020
281
ACTUAL participants
Propofol sedation by nurse anaesthestist
DRUG
Patient-controlled propofol sedation
DRUG
Lead Sponsor
University Hospital, Linkoeping
NCT04408482
NCT07440342
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07017283